Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUAN GARZA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1245642073
CMS profile
4218996
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$6,160.67

171 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,986.51 167
Consulting Fee $1,935.00 1
Education $239.16 3

By paying entity

PY2023 · entire year · sorted by reported total

Page 4 of 4; records 151–171 of 171 matching records. This page contains 21 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUAN GARZA

NPI 1245642073 · CMS profile ID 4218996

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–171 of 171 matching records. This page contains 21 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUAN GARZA, NPI 1245642073, CMS profile ID 4218996. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–171 of 171 matching records. This page contains 21 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JUAN GARZA, NPI 1245642073, CMS profile ID 4218996. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–171 of 171 matching records. This page contains 21 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JUAN GARZA, NPI 1245642073, CMS profile ID 4218996, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–171 of 171 matching records. This page contains 21 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

171 matching records · $6,160.67 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 171 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–171 of 171.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $20.1402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878131 CMS
Celgene Corporation $30.1302/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878083 CMS
AstraZeneca Pharmaceuticals LP $20.4402/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015427639 CMS
BeiGene USA, Inc. $22.0302/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051177793 CMS
BeiGene USA, Inc. $0.7302/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051177801 CMS
E.R. Squibb & Sons, L.L.C. $17.8202/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878135 CMS
Janssen Biotech, Inc. $15.8902/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391205 CMS
AstraZeneca Pharmaceuticals LP $22.1101/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016042051 CMS
GENZYME CORPORATION $21.0001/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050047821 CMS
Gilead Sciences, Inc. $71.7401/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025528419 CMS
Takeda Pharmaceuticals U.S.A., Inc. $98.9501/27/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055390679 CMS
Eisai Inc. $1,935.0001/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045414765 CMS
Seagen Inc. $22.8501/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995817343 CMS
Astellas Pharma US Inc $15.3201/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033883953 CMS
E.R. Squibb & Sons, L.L.C. $16.7801/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878079 CMS
Merck Sharp & Dohme LLC $22.4501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048357437 CMS
Genentech USA, Inc. $21.5901/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040418009 CMS
PFIZER INC. $24.2701/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049310351 CMS
AstraZeneca Pharmaceuticals LP $24.8401/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014859525 CMS
AstraZeneca Pharmaceuticals LP $19.7701/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015933427 CMS
Merck Sharp & Dohme LLC $20.5401/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048746693 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,297.71 20
PY2020 $798.51 23
PY2021 $5,918.95 127
PY2022 $4,144.65 188
PY2023 $6,160.67 171
PY2024 $1,057.22 46
PY2025 $2,127.21 78

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $138,585.60 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $31,626.22 12/08/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933402903
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $21,701.32 11/03/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933402055
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $1,703.00 10/13/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933401305
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $16,233.30 09/08/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933399565
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $10,867.18 08/04/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933396443
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $23,149.59 06/16/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933390277
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $20,004.99 05/19/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933387449
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $11,500.00 04/27/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933386054
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $1,800.00 04/27/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933386061